Virtual Education Program for Congenital Adrenal Hyperplasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a virtual education program can help adolescents and young adults with congenital adrenal hyperplasia (CAH) manage their condition more effectively as they transition into adult care. Participants will be divided into two groups: one will watch a short educational video about managing CAH, while the other will receive standard care education. Those with CAH who are already part of a specific ongoing study are well-suited for this trial. The trial aims to determine if the virtual education improves self-management skills, such as taking medications and scheduling appointments. As an unphased trial, this study provides a unique opportunity to contribute to innovative educational approaches that could enhance self-care for others with CAH.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications, so it's best to discuss this with the study team or your doctor.
What prior data suggests that this virtual education program is safe for adolescents and young adults with CAH?
Research has shown that virtual education programs, like the one in this study, are designed to be safe. This trial uses videos to deliver education, eliminating the need for physical treatments or drugs. As a result, there are no typical medical risks such as side effects or adverse reactions.
Similar studies have used virtual education without any reports of harm. The main goal is to help people manage their health better. This program assists young people with congenital adrenal hyperplasia (CAH) in learning about their condition and caring for themselves as they transition into adulthood.
Participants primarily need to watch video content, making the risk level very low. The focus is on learning and self-care, so safety concerns are minimal.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to helping people with Congenital Adrenal Hyperplasia (CAH) transition to adult care. Unlike current treatments that focus on hormone replacement and managing symptoms, this trial tests a virtual education program. The program offers an engaging video to help patients understand their condition better and set transitional goals, potentially improving their self-management skills. By leveraging technology, this intervention could make managing CAH more accessible and less intimidating for young patients stepping into adult healthcare.
What evidence suggests that this virtual education program is effective for managing congenital adrenal hyperplasia?
This trial will compare a Virtual Education-Based Transition Intervention with usual care for teens and young adults with congenital adrenal hyperplasia (CAH). Research has shown that online education can help young people manage their health as they transition from child to adult care. Studies have found that online lessons improve patients' understanding and management of their condition. For teens and young adults with CAH, this approach aims to prepare them to take charge of their own health care. Early results suggest that virtual education might help them remember important health tasks, such as taking their medicine and making appointments. This method could be a promising way to help young people with CAH become more independent in managing their health.12345
Who Is on the Research Team?
Ruth W Parker, C.R.N.P.
Principal Investigator
National Institutes of Health Clinical Center (CC)
Are You a Good Fit for This Trial?
This trial is for adolescents and young adults aged 16 to 22 with Congenital Adrenal Hyperplasia (CAH), who are already part of the Natural History Study Protocol 06-CH-0011. They must be able to understand English, have internet access, and commit to all study procedures for a year.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Education
Participants receive an 11-minute educational video on CAH focusing on transitional goals
Follow-up Education
Participants receive CAH education again at 6 months
Final Assessment
Participants repeat the questionnaires from their first visit to assess transition readiness and other outcomes
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Education-Based Transition Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institutes of Health Clinical Center (CC)
Lead Sponsor